THNR
Amplify Weight Loss Drug & Treatment ETF
3월 13일 2:42 PM ET (한국 3/14 03:42)
$24.30
-0.11 ▼ -0.45%
🌙 3월 13일 7:47 PM ET (한국 3/14 08:47)
$24.29
-0.01 ▼ -0.05%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -1.46% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -7.09% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -3.04% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.32 | Perf Half Y | 4.01% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.00M | Perf YTD | -3.64% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -10.92% ($27.28) | Perf Year | 9.47% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 30.94% ($18.56) | Perf 3Y | - |
| Dividend Est. | $0.41 (1.7%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 0.79% 0.97% | Perf 5Y | - |
| Dividend TTM | 0.41 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.4 | Perf 10Y | - |
| Dividend Ex-Date | 2025/12/30 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 33.15 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | - | Sales Q/Q | - | SMA20 | -5.06% ($25.6) | Beta | 0.63 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -6.03% ($25.86) | Rel Volume | 0.09 | Prev Close | $24.41 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 0.48% ($24.18) | Avg Volume(3M) | 0.00M | Price | $24.3 |
| IPO | 2024/5/21 | Option/Short | No/Yes | Trades | 8 | Volume | 299 | Change | -0.45% |
뉴스 로딩 중...